MTOR and hepatocellular carcinoma: It’s noted that some pilot studies have identified prognostic models in HCC, including those utilizing either mTOR or Hippo genes [20], however, our work provides a more comprehensive and accurate model for prognostic estimation by combining these two pathways, deepening our understanding of gene set-based predictions.